Quantum Biopharma Class B Subordinate Voting Shares
QNTM
15 hedge funds and large institutions have $527K invested in Quantum Biopharma Class B Subordinate Voting Shares in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 5 closing their positions.
967% more call options, than puts
Call options by funds: $32K | Put options by funds: $3K
38% more capital invested
Capital invested by funds: $383K → $527K (+$144K)
0.01% more ownership
Funds ownership: 0.02% → 0.03% (+0.01%)
12% less funds holding
Funds holding: 17 → 15 (-2)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AI
AdvisorShares Investments
Bethesda,
Maryland
|
+$132K |
| 2 |
Jane Street
New York
|
+$16K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$13.6K |
| 4 |
Wolverine Trading
Chicago,
Illinois
|
+$10.8K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.64K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Group One Trading
Chicago,
Illinois
|
-$15.9K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
-$13.7K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$12K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.41K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$881 |
QNTM Hedge Fund Activity: Q3 2022 in Review
15 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Quantum Biopharma Class B Subordinate Voting Shares (QNTM) for Q3 2022, worth a combined $527K — up 38% from $383K a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of QNTM and 3 opened new positions — a net loss of 2 holders — while 4 trimmed existing stakes and 3 added.
The largest buyer was AdvisorShares Investments, adding an estimated $132K. The largest seller was Group One Trading, cutting an estimated $15.9K.
- 15 institutional investors held Quantum Biopharma Class B Subordinate Voting Shares (QNTM) as of Q3 2022, down from 17 in Q2 2022.
- Funds reported $527K of Quantum Biopharma Class B Subordinate Voting Shares stock for Q3 2022, up 38% quarter-over-quarter.
- 3 funds opened new Quantum Biopharma Class B Subordinate Voting Shares positions in Q3 2022 and 5 closed out, a net change of -2 holders.
- The largest Quantum Biopharma Class B Subordinate Voting Shares buyer in Q3 2022 was AdvisorShares Investments, an estimated $132K added.
- The largest Quantum Biopharma Class B Subordinate Voting Shares seller in Q3 2022 was Group One Trading, an estimated $15.9K sold.
Based on aggregated 13F filings for Q3 2022.